Concepedia

Cost-Utility Analysis of Three Iron Chelators Used in Monotherapy for the Treatment of Chronic Iron Overload in β-Thalassaemia Major Patients: An Italian Perspective

Alessia Pepe, Giuseppe Rossi, Anthony Bentley, Maria Caterina Putti, Ludovica Frizziero, Domenico Giuseppe D’Ascola, Liana Cuccia, Anna Spasiano, Aldo Filosa, Vincenzo Caruso,

Clinical Drug Investigation · 2017 · 18 citations · 31 references

DOI

Concepts

References

31

Global epidemiology of haemoglobin disorders and derived service indicators

Bernadette Modell · Bulletin of the World Health Organization · 2008 · 1.9K citations · Full text

, , +14

Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine.

Caterina Borgna‐Pignatti, Simone Rugolotto, Piero De Stefano et al. · PubMed · 2004 · 1.1K citations

, , +15

A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia

Maria Domenica Cappellini · Blood · 2005 · 719 citations · Full text

, , +13

Beta-thalassemia

Genetics in Medicine · 2010 · 652 citations · Full text

SURVIVAL AND CAUSES OF DEATH IN THALASSAEMIA MAJOR

MariaGrazia Zurlo, Piero De Stefano, Caterina Borgna‐Pignatti et al. · The Lancet · 1989 · 616 citations

, , +5